Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/15/20 → 09/14/25 |
Funding
- Biogen MA Incorporated: $82,738.48
Evaluation of Patient-Reported Outcomes Associated with Natalizumab Use in a Real-World Setting
- Weinstock-Guttman, Bianca (PI)
- Vaughn, Caila (PI)
- McGraw, Corey (CoI)
Project: Research